A case report of a patient with metastatic ocular melanoma who experienced a response to treatment with the BRAF inhibitor vemurafenib.

MLA

Maleka, A., et al. “A Case Report of a Patient with Metastatic Ocular Melanoma Who Experienced a Response to Treatment with the BRAF Inhibitor Vemurafenib.” BMC Cancer, vol. 16, Aug. 2016, p. 634. EBSCOhost, https://doi.org/10.1186/s12885-016-2657-7.

APA

Maleka, A., Åström, G., Byström, P., & Ullenhag, G. J. (2016). A case report of a patient with metastatic ocular melanoma who experienced a response to treatment with the BRAF inhibitor vemurafenib. BMC Cancer, 16, 634. https://doi.org/10.1186/s12885-016-2657-7

Chicago

Maleka, A, G Åström, P Byström, and G J Ullenhag. 2016. “A Case Report of a Patient with Metastatic Ocular Melanoma Who Experienced a Response to Treatment with the BRAF Inhibitor Vemurafenib.” BMC Cancer 16 (August): 634. doi:10.1186/s12885-016-2657-7.